{
    "nctId": "NCT00383500",
    "briefTitle": "Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status",
    "officialTitle": "To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 75,
    "primaryOutcomeMeasure": "Number of Participants With Successful Assessment of Lymphedema by Multiple Frequency Bioimpedance Spectroscopy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Unilateral breast cancer\n* Scheduled to undergo breast surgery and axillary lymph node dissection, with or without breast conserving techniques.\n* Referred to the surgeons of the Stanford University Breast Cancer Program\n* Capacity to provide informed consent.\n* All experimental protocols will be reviewed and approved by the Stanford Institutional Review Board for the Protection of Human Subjects.\n\nExclusion Criteria:\n\n* Other serious systemic illness (renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would confound the study or impair the patients' ability to participate.\n* Recurrent breast cancer or other forms of pre-existing lymphedema.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}